What is a stock summary page? Click here for an overview.
Business Description
Celularity Inc
NAICS : 325412
SIC : 2834
ISIN : US1511901050
Share Class Description:
CELU: Ordinary Shares - Class ADescription
Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from bio-banking segment.
Financial Strength
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Equity-to-Asset | 0.13 | |||||
| Debt-to-Equity | 4 | |||||
| Debt-to-EBITDA | -3.2 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | -10.37 | |||||
| Beneish M-Score | -2.5 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 122.2 | |||||
| 3-Year EBITDA Growth Rate | -84.2 | |||||
| 3-Year EPS without NRI Growth Rate | -100.2 | |||||
| 3-Year FCF Growth Rate | -47.8 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 85.54 | |||||
| 9-Day RSI | 69.86 | |||||
| 14-Day RSI | 59.57 | |||||
| 3-1 Month Momentum % | -29.82 | |||||
| 6-1 Month Momentum % | -45.21 | |||||
| 12-1 Month Momentum % | -69.17 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.19 | |||||
| Quick Ratio | 0.14 | |||||
| Days Inventory | 89.97 | |||||
| Days Sales Outstanding | 75.99 | |||||
| Days Payable | 292.69 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -16.5 | |||||
| Shareholder Yield % | -22.82 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 64.2 | |||||
| Operating Margin % | -82.83 | |||||
| Net Margin % | -72.72 | |||||
| FCF Margin % | -27.01 | |||||
| ROE % | -118.79 | |||||
| ROA % | -24.71 | |||||
| ROIC % | -23.98 | |||||
| 3-Year ROIIC % | 0.06 | |||||
| ROC (Joel Greenblatt) % | -38.62 | |||||
| ROCE % | -43.1 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.85 | |||||
| PB Ratio | 2.37 | |||||
| Price-to-Tangible-Book | 187 | |||||
| EV-to-EBIT | -3.74 | |||||
| EV-to-EBITDA | -5.18 | |||||
| EV-to-Revenue | 2.32 | |||||
| EV-to-Forward-Revenue | 5.24 | |||||
| EV-to-FCF | -8.46 | |||||
| Price-to-GF-Value | 0.14 | |||||
| Earnings Yield (Greenblatt) % | -26.74 | |||||
| FCF Yield % | -29.25 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:CELU
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Celularity Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 48.2 | ||
| EPS (TTM) ($) | -1.567 | ||
| Beta | 1.44 | ||
| 3-Year Sharpe Ratio | -0.92 | ||
| 3-Year Sortino Ratio | -1.12 | ||
| Volatility % | 108.46 | ||
| 14-Day RSI | 59.57 | ||
| 14-Day ATR ($) | 0.196213 | ||
| 20-Day SMA ($) | 1.438 | ||
| 12-1 Month Momentum % | -69.17 | ||
| 52-Week Range ($) | 1.0007 - 5.77 | ||
| Shares Outstanding (Mil) | 23.81 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Celularity Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Celularity Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Celularity Inc Frequently Asked Questions
What is Celularity Inc(CELU)'s stock price today?
The current price of CELU is $1.87. The 52 week high of CELU is $5.77 and 52 week low is $1.00.
When is next earnings date of Celularity Inc(CELU)?
The next earnings date of Celularity Inc(CELU) is .
Does Celularity Inc(CELU) pay dividends? If so, how much?
Celularity Inc(CELU) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers